30009611000001106: Cefalexin 250mg capsules (Mawdsley-Brooks & Company Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Cefalexin 250mg capsules (Mawdsley-Brooks & Company Ltd)
\UK product\Virtual medicinal product\Cefalexin 250mg capsules\Cefalexin 250mg capsules (Mawdsley-Brooks & Company Ltd)
\UK product\Virtual therapeutic moiety\Cefalexin\Cefalexin 250mg capsules\Cefalexin 250mg capsules (Mawdsley-Brooks & Company Ltd)

\Medicinal product\Medicinal product categorized by disposition\Medicinal product containing cephalosporin and acting as antibacterial agent (product)\Medicinal product containing first generation cephalosporin and acting as antibacterial agent (product)\Product containing cefalexin\Cefalexin\Cefalexin 250mg capsules\Cefalexin 250mg capsules (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing beta-lactam\Medicinal product containing beta-lactam and acting as antibacterial agent (product)\Medicinal product containing cephalosporin and acting as antibacterial agent (product)\Medicinal product containing first generation cephalosporin and acting as antibacterial agent (product)\Product containing cefalexin\Cefalexin\Cefalexin 250mg capsules\Cefalexin 250mg capsules (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antibacterial agent (product)\Medicinal product containing beta-lactam and acting as antibacterial agent (product)\Medicinal product containing cephalosporin and acting as antibacterial agent (product)\Medicinal product containing first generation cephalosporin and acting as antibacterial agent (product)\Product containing cefalexin\Cefalexin\Cefalexin 250mg capsules\Cefalexin 250mg capsules (Mawdsley-Brooks & Company Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Aug 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

93677501000001112 Cefalexin 250mg capsules (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

93677601000001111 Cefalexin 250mg capsules (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Cefalexin 250mg capsules (Mawdsley-Brooks & Company Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Cefalexin 250mg capsules (Mawdsley-Brooks & Company Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Cefalexin 250mg capsules (Mawdsley-Brooks & Company Ltd)	Is a	Cefalexin 250mg capsules	true	Inferred relationship	Existential restriction modifier
Cefalexin 250mg capsules (Mawdsley-Brooks & Company Ltd)	Is a	Cefalexin 250mg capsules	false	Inferred relationship	Existential restriction modifier
Cefalexin 250mg capsules (Mawdsley-Brooks & Company Ltd)	Is a	Product containing precisely cefalexin monohydrate 250 milligram/1 each conventional release oral capsule	false	Inferred relationship	Existential restriction modifier
Cefalexin 250mg capsules (Mawdsley-Brooks & Company Ltd)	Has active ingredient	Cefalexin monohydrate	false	Inferred relationship	Existential restriction modifier
Cefalexin 250mg capsules (Mawdsley-Brooks & Company Ltd)	Has manufactured dose form	Conventional release oral capsule	true	Inferred relationship	Existential restriction modifier
Cefalexin 250mg capsules (Mawdsley-Brooks & Company Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Cefalexin 250mg capsules (Mawdsley-Brooks & Company Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Cefalexin 250mg capsules (Mawdsley-Brooks & Company Ltd)	Has specific active ingredient	Cefalexin	true	Inferred relationship	Existential restriction modifier
Cefalexin 250mg capsules (Mawdsley-Brooks & Company Ltd)	Has dispensed dose form	Capsule	true	Inferred relationship	Existential restriction modifier
Cefalexin 250mg capsules (Mawdsley-Brooks & Company Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Cefalexin 250mg capsules (Mawdsley-Brooks & Company Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Cefalexin 250mg capsules (Mawdsley-Brooks & Company Ltd) 28 capsule	Has AMP	True	Cefalexin 250mg capsules (Mawdsley-Brooks & Company Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
93677501000001112	Cefalexin 250mg capsules (Mawdsley-Brooks & Company Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
93677601000001111	Cefalexin 250mg capsules (Mawdsley-Brooks & Company Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module